Cognitive Functions in Brain Tumor Patients
作者： Denise D. Correa
DOI: 10.1016/J.HOC.2006.09.012
关键词: Poison control 、 Psychological intervention 、 Central nervous system disease 、 Medicine 、 Internal medicine 、 Cognition 、 Oncology 、 Brain tumor 、 Clinical trial 、 Quality of life (healthcare) 、 Physical therapy 、 Human factors and ergonomics
摘要: As effective treatment interventions have increased survival rates, there has been greater awareness that many brain tumor patients experience cognitive dysfunction despite adequate disease control. Cognitive difficulties often an impact on quality of life and interfere with the patient's ability to function at premorbid levels; however, incidence in is unknown, because it not investigated systematically. Future prospective clinical trials neuro-oncology should include outcome measures increase understanding contribution delayed effects dysfunction. Language: en
sci-hub.se 参考文章(67)
Meyers Ca, Neurocognitive dysfunction in cancer patients. Oncology. ,vol. 14, pp. 75- ,(2000)
Phillips Pc, Armstrong Cl, Mollman Je, Corn Bw, Ruffer Je, Pruitt Aa, Radiotherapeutic effects on brain function: double dissociation of memory systems. Neuropsychiatry Neuropsychology and Behavioral Neurology. ,vol. 13, pp. 101- 111 ,(2000)
T.J. Postma, C.J. van Groeningen, R.J.G.M. Witjes, J.G.E. Weerts, J.H. Kralendonk, J.J. Heimans, Neurotoxicity of combination chemotherapy with procarbazine, CCNU and vincristine (PCV) for recurrent glioma Journal of Neuro-oncology. ,vol. 38, pp. 69- 75 ,(1998) , 10.1023/A:1005909318270
Cancer neurology in clinical practice Humana Press. ,(2002) , 10.1007/978-1-59259-317-0
L M DeAngelis, J Yahalom, H T Thaler, U Kher, Combined modality therapy for primary CNS lymphoma. Journal of Clinical Oncology. ,vol. 10, pp. 635- 643 ,(1992) , 10.1200/JCO.1992.10.4.635
E A Neuwelt, D L Goldman, S A Dahlborg, J Crossen, F Ramsey, S Roman-Goldstein, R Braziel, B Dana, Primary CNS lymphoma treated with osmotic blood-brain barrier disruption: prolonged survival and preservation of cognitive function. Journal of Clinical Oncology. ,vol. 9, pp. 1580- 1590 ,(1991) , 10.1200/JCO.1991.9.9.1580
Martin Klein, Martin J.B . Taphoorn, Jan J. Heimans, Henk M. van der Ploeg, W. Peter Vandertop, Egbert F. Smit, Sieger Leenstra, Cees A.F. Tulleken, Willem Boogerd, José S.A. Belderbos, Wilmy Cleijne, Neil K. Aaronson, Neurobehavioral Status and Health-Related Quality of Life in Newly Diagnosed High-Grade Glioma Patients Journal of Clinical Oncology. ,vol. 19, pp. 4037- 4047 ,(2001) , 10.1200/JCO.2001.19.20.4037
Christina A Meyers, Kenneth R Hess, WK Alfred Yung, Victor A Levin, None, Cognitive Function as a Predictor of Survival in Patients With Recurrent Malignant Glioma Journal of Clinical Oncology. ,vol. 18, pp. 646- 650 ,(2000) , 10.1200/JCO.2000.18.3.646
M. J. B. Taphoorn, A. Klein Schiphorst, F. J. Snoek, J. Lindeboom, J. G. Wolbers, A. B. M. F. Karim, P. C. Huijgens, J. J. Heimans, Cognitive functions and quality of life in patients with low‐grade gliomas : The impact of radiotherapy Annals of Neurology. ,vol. 36, pp. 48- 54 ,(1994) , 10.1002/ANA.410360111
Jim Hom, Ralph M. Reitan, Neuropsychological correlates of rapidly vs. slowly growing intrinsic cerebral neoplasms. Journal of Clinical and Experimental Neuropsychology. ,vol. 6, pp. 309- 324 ,(1984) , 10.1080/01688638408401221